Imagine having to choose from over 14,000 different treatment scenarios to decide which drugs might be best for a child or a loved one affected by epilepsy. This is what faces many families according to the experts at Stanford and doc.ai who have announced a new type of clinical trial using artificial intelligence (AI).
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,